Current Affairs: Passage of the Day - 20 July 2024 | Current Affairs & General Knowledge - CLAT PDF Download

Directions: Read the passage carefully and answer the questions that follow.
Union Minister Jitendra Singh inaugurated Asia's first health research-related "Pre-clinical Network Facility" under the Coalition of Epidemic Preparedness Innovations (CEPI) at the Regional Centre of Biotechnology under the aegis of the "Translational Health Science & Technology Institute" (THSTI), Faridabad, on Tuesday.
The Coalition for Epidemic Preparedness Innovations (CEPI) has selected BRIC-THSTI as a pre-clinical network laboratory based on its capability to handle BSL3 pathogens. It will be the 9th such network laboratory across the globe and the first such laboratory in all of Asia. The other labs are located in the USA, Europe and Australia. The experimental Animal Facility is one of the largest small animal facility in the country, with a housing capacity of about 75,000 mice, including immune-compromised mice and other species such as rat, rabbits, hamsters, guinea pigs, etc.
Jitendra Singh also inaugurated the "Genetically Defined Human Associated Microbial Culture Collection (Ge-HuMic) Facility" to act as a "repository" for providing microbial cultures to research institutes, universities, and industries for research and development. The facility will serve as a Nodal Resource Centre that will foster national and international collaborations between academic institutions, hospitals and industry. It will also serve as a repository of genetically characterised, specific pathogen-free animals (including cryopreserved embryos and sperm) for the use of researchers within the country.
The Translational Health Science and Technology Institute (THSTI) is an institute of the Biotechnology Research and Innovation Council (BRIC), Department of Biotechnology under the Ministry of Science and Technology, which facilitated the signing of more than a dozen agreements and MoUs with the private sector for vaccine development and research in Nipah virus, Influenza and other respiratory diseases.
It will also facilitate innovative and cutting-edge fundamental research in the country, support translational research to test drug and vaccine candidates, identify biomarkers of disease progression and resolution and foster research collaborations across disciplines and professions with connectivity to industry and academia.
Speaking at the 14th Foundation Day of THSTI, Dr. Jitendra Singh traced back the journey of THSTI since its inception. He also recalled Dr M.K Bhan and his efforts in starting this facility. The Minister said, "In a very short span of 14 years, the institute has achieved many landmarks and there has been an upward graph throughout the COVID pandemic, which marked its peak and helped realise its importance, gave recognition to the efforts of this institute". He also highlighted that the Department of Bio-technology is also not very old.
The Minister appreciated DBT's steady progress despite the dearth of resources. He also assured to press and support the needs of the department regarding office infrastructure, etc.
[Excerpt from Economic Times “Asia’s First Pre-Clinical Network Facility Inaugurated in Faridabad” Dated 20/07/24]

Q1: Where was Asia's first Pre-clinical Network Facility for health studies opened?
(a) Mumbai, Maharashtra
(b) Faridabad, Haryana
(c) Bengaluru, Karnataka
(d) Kolkata, West Bengal

  View Answer

Q2: What is the main goal of the Coalition for Epidemic Preparedness Innovations (CEPI)?
(a) To provide free healthcare to underprivileged regions
(b) To accelerate the development of vaccines for infectious diseases
(c) To fund hospitals and medical facilities
(d) To conduct global health awareness campaigns

  View Answer

Q3: Which institute has been designated by CEPI as a pre-clinical network laboratory due to its ability to handle Biosafety Level 3 (BSL3) pathogens?
(a) Indian Institute of Science (IISc)
(b) Translational Health Science and Technology Institute (THSTI)
(c) All India Institute of Medical Sciences (AIIMS)
(d) National Institute of Virology (NIV)

  View Answer

Q4: How many pre-clinical network facilities are there globally, including the one in Faridabad?
(a) Seven
(b) Eight
(c) Nine
(d) Ten

  View Answer

Q5: What is a significant feature of the Experimental Animal Facility at the Pre-clinical Network Facility in Faridabad?
(a) It can hold about 75,000 mice and other animals
(b) It focuses exclusively on large animals
(c) It is used for human clinical trials
(d) It has the largest living area for primates in Asia

  View Answer